NCT02672709View on ClinicalTrials.gov

Apixaban in Hemodialysis

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
End-stage Renal Disease
Interventions
DRUG

apixaban

Trial Locations (1)

Unknown

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT02672709 - Apixaban in Hemodialysis | Biotech Hunter | Biotech Hunter